Hochschulschrift
Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
19 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen
Westfälische Wilhelms-Universität Münster, Dissertation, 2017
- Classification
-
Medizin, Gesundheit
- Keyword
-
Krebs
Onkologie
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:23 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2017
Other Objects (12)
Comparison of tumor heterogeneity assessed with textural parameters in 68Ga-PSMA PET/CT and 177Lu-PSMA SPECT/CT in patienst with metastatic prostate cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
![[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer](/assets/placeholder/searchResultMediaUnknown.png)
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
Diagnostic performance of [18f]fluorocholine and [68ga]ga-psma pet/ct in prostate cancer: a comparative study
Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
Comparison of tumor heterogeneity assessed with textural parameters in 68Ga-PSMA PET/CT and 177Lu-PSMA SPECT/CT in patienst with metastatic prostate cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
Diagnostic performance of [18f]fluorocholine and [68ga]ga-psma pet/ct in prostate cancer: a comparative study
Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
Comparison of tumor heterogeneity assessed with textural parameters in 68Ga-PSMA PET/CT and 177Lu-PSMA SPECT/CT in patienst with metastatic prostate cancer
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer
Diverse PSMA expression in primary prostate cancer: reason for negative [68Ga]Ga-PSMA PET/CT scans? Immunohistochemical validation in 40 surgical specimens
68Ga-HBED-CC-PSMA PET/CT versus histopathology In primary localized prostate cancer: a voxel-wise comparison
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
Diagnostic performance of [18f]fluorocholine and [68ga]ga-psma pet/ct in prostate cancer: a comparative study